Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 28/03/2023

Debbie Rigby rounds up the latest in research news Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk A systematic review and meta-analysis was performed to investigate the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients at high bleeding risk. A 1- or 3-month abbreviated DAPT

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘We need more pharmacists’

Hmmm…how could we possibly get more pharmacists to go rural…hmmm….oh wait! What’s that thing called again? You know…it starts with…

John Smith

What does the future look like for CWH/Sigma shareholders?

But doesn’t this change as they slowly cripple their competition? It’s the classic Walmart move. Walk in, kill the competition…

John Smith

What does the future look like for CWH/Sigma shareholders?

I’m not sure if I’m just cynical but Ponraj came across as incredibly naive in this article. He was surprised…

John Smith

‘Doctor of Pharmacy’ title announced

Will any of this lead to direct claiming from Medicare for our new doctors?

John Smith

Research Roundup

Previous Feminised workforce opting for part-time roles

Next 'Strong supporter’ of pharmacy named NSW Health Minister

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Feminised workforce opting for part-time roles

Next 'Strong supporter’ of pharmacy named NSW Health Minister

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.